Continue your journey online

Have burning questions about excipient functionalities, selection criteria, or their role in drug formulation? Join us as we bring together a seasoned excipient expert to address your queries, share insights, and offer a deeper understanding of these vital components. Whether you're a pharmaceutical profes...

The global gummy vitamin market is expected to reach 10.6 billion by 2025 and gummies are gaining traction as a drug delivery system -- especially for children and seniors who resist taking pills, capsules and liquids. Mitchell Slade, who brings more than 20 years of gummy manufacturing experience at Natur...

Join us for a series of rapid-fire talks on disruptive manufacturing technologies. • AI - Unleashing the potential of AI in pharmaceutical manufacturing to streamline processes, enhance efficiency, and ensure product quality • Advanced Manufacturing - Delving into the latest advanced manufacturing ...

The successful execution of technical transfer and PPQ at CDMOs is fundamental to ensuring the quality, robustness, and consistency of pharmaceutical products. By adhering to rigorous protocols, CDMOs can effectively transfer manufacturing processes and establish reliable, robust processes, ultimately cont...

• Beyond traditional roles: Explore how excipients are no longer passive additives but active contributors to drug efficacy and delivery, offering diverse functionalities • Precision medicine and tailored therapies: Delve into the role of excipient solutions in enabling precision medicine by allowing...

The growing awareness of the environmental and health risks associated with (PFAS) has led to a global movement to phase out these chemicals from various products. In the pharmaceutical industry, PFAS have been used in some excipients due to their unique properties but concerns about potential health effe...

This session provides an overview of the Drug Master File (DMF) regulatory framework and registration pathways covering Active Pharmaceutical ingredients (APIs), Excipients and Packaging Materials. The aim is to provide an overview of the local requirements and advise on the best and quickest route to the ...

How can we become truly patient-centric? This session will explore strategies for deeper collaboration between big pharma and patients, set against the backdrop of an evolving healthcare landscape where patient voices are key to innovation. Explore dynamic pathways for incorporating patient insights int...

Antibody-drug conjugates (ADCs) are pioneering biologics that merge antibodies’ specificity with small molecules’ potency. With a handful of FDA-approved ADCs in the market and many under development, ADCs are poised to revolutionize therapeutics. This talk examines the complexities of ADC production, emph...

• Why DSCSA was created by US Congress, some history of past undertakings • Who’s who and what’s what with DSCSA trading partner roles for drug manufacturers, repackagers, wholesale distributors, 3rd party logistics & service providers, dispensers Challenges for regulatory compliance with DSCSA from...

This session will provide a comprehensive overview of the challenges and opportunities in decarbonizing pharmaceutical supply chains, showcasing the potential of industry-wide programs like Energize and the practical guidance offered by the PSCI Decarbonization Maturity Model. • Assessing the challenge...

Exploring the growing role of 3D printing in pharmaceutical manufacturing, including personalized medication and dosage forms - Pharmaceutical 3D printing is a rapidly growing field, with more and more research groups in academia and industry investing time and resources to investigate its use to personali...

A holistic view of the environmental impact of drug delivery devices. Exploring the challenges, obstacles, and opportunities to decarbonize the value chain and embed circularity. A call to action for collaboration across all stakeholders

The following session has been SOLD OUT. For any inquiries, please contact a member of staff on the day Discover the latest trends and developments in outsourcing over lunch and connect with your peers in this exclusive session What’s new in outsourcing? Find out in our CDMO panel discussion and networki...

One of the problems that today US suffers is the persistent shortages in pharmaceuticals. The concentration of key products in countries as China and India is a risk for the United States and a necessity to diversify and include new partners. Special efforts are needed to have supply chain resiliency. M...

Cyclodextrins (CDs) - explore novel applications in neurodegenerative diseases, gene therapy, and biotechnology, showcasing innovative structures, mechanisms, challenges, and results, with a focus on Alzheimer's, Parkinson's, rare genetic disorders, and potential expansion to longevity and infectious disea...

The Pharma and Life Sciences industry confronts a pressing challenge—a substantial talent shortage compounded by the effects of the Great Resignation. To remain competitive and seize emerging opportunities, companies must prioritize both external hiring and internal mobility strategies. This pivotal issue ...

The following session has been SOLD OUT. For any inquiries, please contact a member of staff on the day Take a break from the show floor and join us for a bite, network with colleagues, and stay informed with the latest updates and insights on US Pharma regulations. Join attorneys from Womble Bond Dickin...

Bioproduction in the US pharmaceutical industry is crucial for delivering life-saving medications efficiently. Advancements in biotechnology and rising demand are driving rapid evolution in bioproduction. While state-of-the-art facilities and strict regulations define the sector, challenges in scalability,...

Join our opening keynote to review the current state of sustainable practices, environmental impact, and the road towards a greener future for pharma – how do we get there faster?

With the cost of drug development rising and current processes slow and expensive, there is a growing need for new ways to make drugs. Join this session to learn how to disrupt the current model for more efficient production, and speed to market.

Data analytics is playing an increasingly important role in helping companies achieve supply chain excellence. By collecting and analyzing data, companies can gain insights into their supply chains that can help them improve efficiency, reduce costs, and improve customer service • How Data analytics ca...

US healthcare industry has undergone tremendous digital transformation in recent years, but critical care access to lower income ethnicities is still in its nascency. This population have historically showcased substantial hesitation to seek any timely medical assistance. While lack of sufficient financial...

In today's rapidly evolving pharmaceutical landscape, sustaining progress through periods of uncertainty is paramount. To navigate the unknown successfully, pharmaceutical companies need to adapt, innovate, and prioritize sustainability. Join our Q&A and listen to our experts discuss best practices on how ...

Changing the world one film at a time" At Jurata we are focused on eliminating the need for cold chain storage of vaccines and biologics, including mRNA-LNPs, in order to improve global health equity. Our novel stabalization technology is 10x more efficient to produce than lyophilized products and allows ...

Common high-performance lipids and surfactants were used to improve the dissolution rate of furosemide as a model compound for BCS Class II and Class IV active pharmaceutical ingredients. Furosemide equilibrium solubility was measured throughout an HLB range (1-16) of liquid lipids and surfactants. Furosem...

The story of how patient advocacy, patient centric design, and partnership is rebuilding the global pharmecutical supply chain to ensure access to all.

This presentation will consider the following topics: • Why is it important for pharma companies to use the correct grade of excipient in their drug formulation development? • What should pharma companies do to ensure their excipient supply chain is secure and their excipients are of the correct gra...

The pharmaceutical industry is facing increased pressure to reduce costs, and one approach is to improve manufacturing efficiency. Join our panel, where experts will review the latest technologies, re-design processes, and optimizing workflows, so drug manufacturers can reduce costs. • Why Expanding ...

In Pharma, excipients, often underappreciated despite their essential role in drug formulation and delivery, are gaining renewed attention. With growing investments in technology and increasing consumer demand for natural ingredients, excipients are taking on an expanded role. Join our esteemed panel of e...

Join us as our experts delve into the current state of pharmaceutical manufacturing on American soil, examining the drivers, challenges, and outcomes of the onshoring trend within the US pharma industry. In this session you will: • Examine case studies and success stories that highlight the progress a...

Discover the burgeoning pharmaceutical landscape in the heart of the Middle East, where Saudi Arabia stands as a beacon of opportunity. Explore new frontiers and understand the potential for innovation and growth in this dynamic market.

The pharmaceutical industry's reputation greatly improved during the pandemic, an era that not only underscored its critical contributions but also shone a light on the imperative need of embracing diversity, equity, and inclusion (DEI). Motivated by both social movements and the unique demands of the pand...

Ingenza is changing the game in drug substance production by embracing the concept of employing the best of what both chemistry and biology have to offer. We integrate fermentative, biocatalytic and chemical synthetic transformations at any stage in the manufacturing process. We are versatile and adaptable...

The following session has been SOLD OUT. For any inquiries, please contact a member of staff on the day Kickstart your CPHI North America with a coffee and pastry, connect with your peers, and listen to exclusive content surrounding patient-centric development The challenge of ensuring medication accep...

Difficulties Meeting US FDA Regulatory Requirements

An open conversation with two women at different stages of their careers in pharma. The discussion will delve into the diverse experiences, challenges, and opportunities facing women in our industry. Prepare for a discussion that will explore the evolution of gender diversity, personal and professional ...

Join us as our experts delve into the current state of pharmaceutical manufacturing on American soil, examining the drivers, challenges, and outcomes of the onshoring trend within the US pharma industry • Examining case studies and success stories that highlight the progress and challenges in realizing...

Leveraging Data Analytics for Build a More Resilient Supply Chain. Today, patients in the United States and around the world depend on medicines—and the ingredients used to make those medicines—sourced from and manufactured around the globe. The recent pandemic, geopolitical, and natural events have not on...

Discover the compelling link between employee wellness, engagement, and company success. Learn practical strategies to enhance employee well-being, boost recruitment efforts, and cultivate a positive corporate culture. Explore how wellness initiatives drive sales performance and leadership effectiveness. G...

In the rapidly evolving digital ecosystem of pharmaceutical development, there is a growing importance for the integration and management of diverse data to help drive affordable success. This presentation will delve into the realm of big data and how comprehensive data management impacts parameter pred...

Reviewing the outcome of the inflation reduction act and how it is affecting pharmaceutical manufacturers and distributors in managing drug pricing within the supply chain, including:
Examining broader economic and market trends influencing drug pricing within the supply chain economy and their eff...

Common high-performance lipids and surfactants were used to improve the dissolution rate of furosemide as a model compound for BCS Class II and Class IV active pharmaceutical ingredients. Furosemide equilibrium solubility was measured throughout an HLB range (1-16) of liquid lipids and surfactants. Furosem...

Excipients for pharmaceutical processes – How to identify opportunities for novel excipients that solve formulation and process challenges"; Needs of the industry for novel excipients, ways to identify current gaps and work together to resolve them, 1-2 key examples of common process challenges that might ...

It can be difficult to stand out when you’re looking to attract new pharma partners. Reputation and referrals are key, but they aren’t always enough. To be seen as unique and increase awareness with potential partners, consider examining and better establishing your brand, so your audiences know what you s...

As global awareness of environmental concerns deepens, so does our responsibility to ensure that our endeavors align with sustainability goals and allow us to serve our customers on a green and sustainable way. Joint us to discuss the real life examples of how Thermo Fisher Scientific approaches green chem...